Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
It seems we are on the right track and more focused instead of being all over.
Чем вы больше всего довольны в вашем пакете компенсаций?
Health Care insurance & Vision Plan
Что вам больше всего нравится в команде руководства?
Some of the individuals in the LT are still in toxic mode.
Каковы самые лучшие качества в вашей команде?
The team is willing to turn on the page and start with a fresh mindset; however, the SVP still has the old attitude. He does not motivate or inspire employees.
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
I like the new culture and the new LT members. They are sharp and have been in the industry for years. They will make a positive change to the company.
Что приносит вам больше всего счастья/радости на работе?
It makes me happy knowing that we can help patients in need. The KEAP program is a great example of what the company offers for people who cannot afford to pay for the drug.
Other Employee Reviews for Karyopharm Therapeutics
×